FDA approves landmark pancreatic cancer drug that's shown to improve survival
NPR · LC · trust 54/100
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.
Read the original at NPR →
Open in TruthVane →